As the development of CKD-associated CVD is closely related to CKD-inherent risk factors19, we treated cardiac cells with uremic toxins to search for the causes of CKD-induced PGC1α downregulation and mitochondrial energy metabolism dysfunction. This evidence concerns the gene PPARGC1A and chronic kidney disease.